Cushing Syndrome from Topical Foam Steroid Use in an Adolescent Male

Arnaldi G , Angeli A , Atkinson AB , et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593-5602.

Etxabe J , Vazquez JA . Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf). 1994;40:479-484.

Schuff KG . Issues in the diagnosis of Cushing’s syndrome for the primary care physician. Primary Care Clin Office Pract. 2003;30:4.

Forget H , Lacroix A , Cohen H . Persistent cognitive impairment following surgical treatment of Cushing’s syndrome. Psychoneruoendocrinology. 2002;27:367-383.

Williams RH , Larsen PR , Kronenberg HM , et al. Williams Textbook of Endocrinology, 10th ed. St. Louis: Elsevier, 2003.

Kumar S , Singh RJ , Reed AM , Lteif AN . Cushing’s syndrome after intraarticular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics. 2004;113:1820-1824.

Allen DB , Bielory L , Derendorf H , et al. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol. 2003;112:S1-S40.

Ermis B , Ors R , Tastekin A , Ozkan B . Cushing’s syndrome secondary to topical corticosteroids abuse. Clin Endocrinol. 2003;58:795-796.

Vermeer H , Hendriks-Stegeman BI , van der Burg B , et al. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab. 2003;88:277-284.

Murray L . Physicians’ Desk Reference. Montvale, NJ: Medical Economics, 2001.